Skip to content

Member

Tiemo WÖLKEN

S&D · Germany

Group
S&D
Country
Germany
Roll-call participation
69.2 %ⓘ of 620 roll calls in office · chamber median 90.6 % · whole term, final votes
With majority line
96.7 %ⓘ of 429 votes where the group had a line · S&D median 97.1 %
More facts (5)
National party
SPD Sozialdemokratische Partei Deutschlands
In office
Since 16 Jul 2024
Against clear line
10 of 423 votesⓘ
Committees
ENVI, JURI (substitute), SANT
Member id
185619
More

Record

The member’s figures against the median of their group and of the chamber. Each vote counts the member in the group they belonged to that day.

Roll-call participation ⓘ

69.2 %

429 of 620 final votes while in office

S&D median: 89.5 % (−20.3 pts)

Chamber median: 90.6 %

With majority line ⓘ

96.7 %

415 of 429 votes where their group had a line

S&D median: 97.1 % (−0.4 pts)

Against clear line ⓘ

2.4 %

10 of 423 votes where their group had a clear line

4 opposite (for ↔ against), 6 abstained against the line

Abstention ⓘ

2.6 %

11 of 429 votes cast

Participation 69.2 % — S&D median 89.5 %, 137 members.ⓘ
Data as a table
Participation among the 137 members of the S&D with enough votes.
FigureParticipation
Tiemo WÖLKEN69.2 %
S&D median89.5 %
Lowest in the group48.1 %
Highest in the group99.8 %
Members137
With majority line 96.7 % — S&D median 97.1 %, 137 members.ⓘ
Data as a table
With majority line among the 137 members of the S&D with enough votes.
FigureWith majority line
Tiemo WÖLKEN96.7 %
S&D median97.1 %
Lowest in the group86.7 %
Highest in the group99.8 %
Members137
  • Whole term, 620 final votes; 620 of 794 decisions had a final vote recorded by name. The dots are the other members of S&D; no ranks.
  • “No vote recorded” is not the same as absent: leave, illness and chairing the sitting look the same.
  • A group’s line is inferred from its members’ votes — Parliament publishes no whip.

Votes, 620

Export

Every final roll-call vote of the term with the member’s position, newest first.

Result: for–against–abstained. Majority line: how most of the member’s group voted that day (“Tie” when no position won). ≠ group marks a vote otherwise than a clear line (at least two thirds, with at least 10 members voting) of their group.
DateDecisionResultPositionMajority line
21 Jan 2026Request for opinion from the Court of Justice on the compatibility with the Treaties of the proposed EU-Mercosur Partnership Agreement (EMPA) and Interim Trade Agreement (ITA) Adopted 334 for, 324 against, 11 abstainedPosition: Against Majority line: Against
21 Jan 2026Implementation of the common foreign and security policy – annual report 2025 Adopted 392 for, 179 against, 83 abstainedPosition: For Majority line: For
21 Jan 2026Implementation of the common security and defence policy – annual report 2025 Adopted 395 for, 197 against, 70 abstainedPosition: For Majority line: For
21 Jan 2026Human rights and democracy in the world and the European Union’s policy on the matter – annual report 2025 Adopted 421 for, 120 against, 108 abstainedPosition: For Majority line: For
21 Jan 2026Addressing impunity through EU sanctions, including the EU Global Human Rights sanctions regime (so-called ‘EU Magnitsky Act’) Adopted 440 for, 127 against, 59 abstainedPosition: For Majority line: For
20 Jan 2026Framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interest Passed 503 for, 57 against, 108 abstainedPosition: For Majority line: For
20 Jan 2026The 28th Regime: a new legal framework for innovative companies Adopted 492 for, 144 against, 28 abstainedPosition: For Majority line: For
20 Jan 2026Just transition directive in the world of work: ensuring the creation of jobs and revitalising local economies Adopted 420 for, 207 against, 20 abstainedPosition: For Majority line: For
20 Jan 2026Safeguarding and promoting financial stability amid economic uncertainties Adopted 491 for, 83 against, 84 abstainedPosition: For Majority line: For
20 Jan 2026Humanitarian aid in a time of polycrisis – reaffirming our principles for a more effective and ambitious response to humanitarian crises Adopted 444 for, 153 against, 55 abstainedPosition: For Majority line: For
20 Jan 2026Reform of the European Electoral Act – hurdles to ratification and implementation in the Member States Adopted 417 for, 234 against, 9 abstainedPosition: For Majority line: For
18 Dec 2025Arbitrary arrest and sentencing of academics Bahruz Samadov and Igbal Abilov in Azerbaijan Adopted 477 for, 7 against, 69 abstainedPosition: No vote recorded Majority line: For
18 Dec 2025Mass kidnapping of children in Nigeria, including from St Mary’s Catholic School in Papiri Adopted 519 for, 2 against, 50 abstainedPosition: No vote recorded Majority line: For
18 Dec 2025Grave political situation in Guinea-Bissau after the coup of 26 November Adopted 535 for, 0 against, 42 abstainedPosition: No vote recorded Majority line: For
18 Dec 2025Implementation of the rule of law conditionality regime Adopted 386 for, 184 against, 15 abstainedPosition: No vote recorded Majority line: For
18 Dec 2025Decarbonisation and modernisation of EU fisheries, and the development and deployment of fishing gear Adopted 450 for, 93 against, 37 abstainedPosition: No vote recorded Majority line: For
18 Dec 2025Continuous Belarusian hybrid attacks against Lithuania Adopted 438 for, 37 against, 48 abstainedPosition: No vote recorded Majority line: For
17 Dec 2025Application of the ‘safe third country’ concept Negotiating mandate approved 384 for, 237 against, 31 abstainedPosition: No vote recorded Majority line: Against
17 Dec 2025Establishment of a list of safe countries of origin at Union level Negotiating mandate approved 396 for, 202 against, 56 abstainedPosition: No vote recorded Majority line: Against
17 Dec 2025Phasing out Russian natural gas imports, improving monitoring of potential energy dependencies Passed 500 for, 120 against, 32 abstainedPosition: No vote recorded Majority line: For
17 Dec 2025Deforestation Regulation: certain obligations of operators and traders Passed 405 for, 242 against, 8 abstainedPosition: No vote recorded Majority line: Against
17 Dec 2025European High Performance Computing Joint Undertaking (EuroHPC) Passed 604 for, 37 against, 18 abstainedPosition: No vote recorded Majority line: For
17 Dec 2025EU/Jordan Agreement for scientific and technological cooperation: terms and conditions for the participation of Jordan in the Partnership for Research and Innovation in the Mediterranean Area (PRIMA) Consent given 627 for, 13 against, 5 abstainedPosition: No vote recorded Majority line: For
17 Dec 2025Simplification of the content and presentation of information to be disclosed concerning environmentally sustainable activities and simplification of certain technical screening criteria for determining whether economic activities cause no significant harm to environmental objectives Objection failed 230 for, 402 against, 28 abstainedPosition: No vote recorded Majority line: For
17 Dec 2025Military Mobility Adopted 493 for, 127 against, 38 abstainedPosition: No vote recorded Majority line: For
17 Dec 2025European Defence Readiness 2030: assessment of needs Adopted 425 for, 120 against, 96 abstainedPosition: No vote recorded Majority line: For
17 Dec 2025Digitalisation, artificial intelligence and algorithmic management in the workplace – shaping the future of work Adopted 480 for, 83 against, 94 abstainedPosition: No vote recorded Majority line: For
17 Dec 2025European Citizens’ Initiative ‘My voice, my choice: for safe and accessible abortion’ Adopted 358 for, 202 against, 79 abstainedPosition: No vote recorded Majority line: For
16 Dec 2025Bilateral safeguard clause of the EU-Mercosur Partnership Agreement and the EU-Mercosur Interim Trade Agreement for agricultural products Passed 431 for, 161 against, 70 abstainedPosition: For Majority line: For
16 Dec 2025Amending the Directive on alternative dispute resolution for consumer disputes Amendment 1 rejected 122 for, 470 against, 69 abstainedPosition: Against Majority line: Against
16 Dec 2025Incentivising defence-related investments in the EU budget to implement the ReArm Europe Plan Passed 519 for, 119 against, 25 abstainedPosition: For Majority line: For
16 Dec 2025Amending certain CAP Regulations as regards the conditionality system, types of intervention in the form of direct payment, types of intervention in certain sectors and rural development and annual performance reports, data and interoperability governance, suspensions of payments annual performance clearance and controls and penalties Passed 629 for, 17 against, 16 abstainedPosition: For Majority line: For
16 Dec 2025Providing macro-financial assistance to Jordan Passed 585 for, 34 against, 45 abstainedPosition: For Majority line: For
16 Dec 2025Brexit Adjustment Reserve Passed 619 for, 6 against, 37 abstainedPosition: For Majority line: For
16 Dec 2025Corporate sustainability reporting and due diligence requirements Passed 428 for, 218 against, 17 abstainedPosition: Against Majority line: Against
16 Dec 2025Mobilisation of the European Globalisation Adjustment Fund for Displaced Workers: application EGF/2025/003 SE/Northvolt – Sweden Passed 578 for, 54 against, 30 abstainedPosition: For Majority line: For
16 Dec 2025Genetically modified maize NK603 Objection passed 479 for, 173 against, 8 abstainedPosition: For Majority line: For
16 Dec 2025Genetically modified sugar beet KWS20-1 Objection passed 455 for, 169 against, 8 abstainedPosition: For Majority line: For
16 Dec 2025Relations between the EU and Saudi Arabia Adopted 417 for, 131 against, 108 abstainedPosition: Abstained Majority line: For
27 Nov 2025Amending Regulations on the Internal Market Information System (IMI) and on the single digital gateway as regards certain harmonisation requirements on transparency Passed 400 for, 77 against, 132 abstainedPosition: No vote recorded Majority line: For
27 Nov 2025Harmonised requirements in the internal market on transparency of third countries interest representation Passed 392 for, 88 against, 133 abstainedPosition: No vote recorded Majority line: For
27 Nov 2025Post-election killings and the deteriorating human rights situation in Tanzania, including the case of imprisoned opposition leader Tundu Lissu Adopted 539 for, 0 against, 27 abstainedPosition: No vote recorded Majority line: For
27 Nov 2025Escalating repression of the Baha’is in Iran Adopted 549 for, 7 against, 31 abstainedPosition: No vote recorded Majority line: For
27 Nov 2025Rule of law and human rights situation in Tunisia, particularly the case of Sonia Dahmani Adopted 464 for, 58 against, 75 abstainedPosition: No vote recorded Majority line: For
27 Nov 2025Implementation of the EU-UK Trade and Cooperation Agreement Adopted 490 for, 41 against, 74 abstainedPosition: No vote recorded Majority line: For
27 Nov 2025EU strategy for the rights of persons with disabilities post-2024 Adopted 490 for, 9 against, 109 abstainedPosition: No vote recorded Majority line: For
27 Nov 2025Application of the Treaty provisions related to the principles of subsidiarity and proportionality and the role of national parliaments in the EU legislative process Adopted 337 for, 245 against, 12 abstainedPosition: No vote recorded Majority line: Against
27 Nov 2025Escalation of the war and the humanitarian catastrophe in Sudan Adopted 503 for, 32 against, 52 abstainedPosition: No vote recorded Majority line: For
27 Nov 2025Political situation in Myanmar including the humanitarian crisis of the Rohingya Adopted 519 for, 3 against, 57 abstainedPosition: No vote recorded Majority line: For
27 Nov 2025EU position on the proposed plan and EU engagement towards a just and lasting peace for Ukraine Adopted 401 for, 70 against, 90 abstainedPosition: No vote recorded Majority line: For

Show all 50 votes on this page

Roll-call participation

One cell per sitting while in office, shaded by the share of that day’s roll calls the member voted in. The official attendance register is kept separately by Parliament.

No vote recorded on 25 of 80 sittings with roll calls.

"No vote recorded" is not the same as absent: leave, illness and chairing the sitting look the same.

Data as a table

Voting neighbours

Members who voted the same way most often in the roll calls they both took part in, within and outside the member’s group (group at the date of each vote), over all roll calls of the term.

At least 200 shared roll calls over at least six months in office together. Within = both sat in the same group on the date of the vote; a member who changed group can appear on both lists. Baseline = the median agreement of all pairs of members of the groups the two sat in on the date of each shared vote (within: the group they shared; outside: the two groups), weighted by the votes they shared in each combination.

Within S&D

Agreement: roll calls where both cast the same position, of the roll calls both voted in while in the same group (“shared”); a count below 50 shared. Baseline: the median agreement of every pair of members of that group.
SelectMemberGroupCountryAgreementBaseline
René REPASI S&DGermany98 % of 4 172 shared93 %
Gabriele BISCHOFF S&DGermany97 % of 4 319 shared93 %
Tobias CREMER S&DGermany97 % of 4 120 shared93 %
Jens GEIER S&DGermany97 % of 3 908 shared93 %
Katarina BARLEY S&DGermany97 % of 3 157 shared93 %
Vivien COSTANZO S&DGermany97 % of 4 360 shared93 %
Udo BULLMANN S&DGermany97 % of 3 698 shared93 %
Matthias ECKE S&DGermany97 % of 4 089 shared93 %
Birgit SIPPEL S&DGermany97 % of 3 778 shared93 %
Delara BURKHARDT S&DGermany97 % of 3 492 shared93 %

Outside the group

Agreement: roll calls where both cast the same position, of the roll calls both voted in while in different groups (“shared”); a count below 50 shared. Baseline: the median agreement of every pair of members of the groups the two sat in on those votes (groups at the date, weighted by the votes shared in each combination).
SelectMemberGroupCountryAgreementBaseline
Gerben-Jan GERBRANDY RenewNetherlands90 % of 4 388 shared86 %
Raquel GARCÍA HERMIDA-VAN DER WALLE RenewNetherlands89 % of 4 390 shared86 %
Martin HOJSÍK RenewSlovakia89 % of 4 146 shared86 %
Ľudovít ÓDOR RenewSlovakia89 % of 4 126 shared86 %
Yvan VEROUGSTRAETE RenewBelgium89 % of 3 653 shared86 %
Lucia YAR RenewSlovakia89 % of 4 350 shared86 %
Charles GOERENS RenewLuxembourg89 % of 4 074 shared86 %
Michal WIEZIK RenewSlovakia89 % of 4 083 shared86 %
Jana TOOM RenewEstonia89 % of 3 745 shared86 %
Dainius ŽALIMAS RenewLithuania89 % of 4 091 shared86 %

Work

Seats in committees, delegations and intergroups, and the dossiers the member leads, shadows or negotiates.

Seats

Body: the committee, delegation or intergroup, with its kind. Role: the member’s role in it. From, To: the dates of the seat (“now” while it lasts).
BodyRoleFromTo
Committee on the Environment, Climate and Food SafetyENVI CommitteeMember20 Jan 2025now
Committee on Legal AffairsJURI CommitteeSubstitute19 Jul 2024now
Committee on Public HealthSANT CommitteeMember23 Jan 2025now
Delegation for relations with South AfricaD-ZA DelegationMember19 Sept 2024now
Intergroup on Trade UnionsIG10-24 Intergroup / working groupMember31 Jan 2025now
Intergroup on the Welfare and Conservation of AnimalsIG10-27 Intergroup / working groupMember8 Jan 2025now
Committee on the Environment, Public Health and Food SafetyENVI CommitteeMember19 Jul 202419 Jan 2025
Subcommittee on Public HealthSANT SubcommitteeMember19 Jul 202419 Jan 2025

Show all 8 seats

Dossiers

Dossier: the procedure the declaration names (“No dossier named” for a delegation without one). Role: rapporteur, shadow rapporteur, negotiator or delegation. Committee: the committee that appointed them. Date: of the declaration.
DossierRoleCommitteeDate
European Union regulatory fitness and subsidiarity and proportionality – report on Better Law-Making covering 2025 and 2026Shadow rapporteurJURI7 Jul 2026
Replacing S&D shadow rapporteur for the Amending Regulations (EU) 2024/1689 and (EU) 2018/1139 as regards the simplification of the implementation of harmonised rules on artificial intelligence (Digital Omnibus on AI)Trilogue negotiator6 May 2026
Clean corporate vehiclesRapporteurENVI21 Apr 2026
Amending Regulations (EU) 2017/745 and (EU) 2017/746 as regards simplifying and reducing the burden of the rules on medical devices and in vitro diagnostic medical devices, and amending Regulation (EU) 2022/123 as regards the support of the European Medicines Agency for the expert panels on medical devices and Regulation (EU) 2024/1689 as regards the list of Union harmonisation legislation referred to in its Annex IShadow rapporteurSANT15 Apr 2026
Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act)Opinion rapporteurJURI10 Mar 2026
European Union regulatory fitness and subsidiarity and proportionality – report on Better Law-Making covering 2023 and 2024Shadow rapporteurJURI17 Nov 2025
Amending Directives 2000/14/EC, 2011/65/EU, 2013/53/EU, 2014/29/EU, 2014/30/EU, 2014/31/EU, 2014/32/EU, 2014/33/EU, 2014/34/EU, 2014/35/EU, 2014/53/EU, 2014/68/EU and 2014/90/EU of the European Parliament and of the Council as regards digitalisation and common specificationsShadow rapporteur for an opinionENVI21 Oct 2025
Amending Regulations (EU) No 765/2008, (EU) 2016/424, (EU) 2016/425, (EU) 2016/426, (EU) 2023/1230, (EU) 2023/1542 and (EU) 2024/1781 as regards digitalisation and common specificationsShadow rapporteur for an opinionENVI21 Oct 2025
Laying a framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interest, and amending Regulation (EU) 2024/795Shadow rapporteur for an opinionENVI23 Jun 2025
Laying a framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interest, and amending Regulation (EU) 2024/795Shadow rapporteurSANT21 May 2025

Show all 23 dossier roles

Topics they work on (model-assigned)

Counts: dossiers they spoke on, led or amended, and their questions and motions.

In the chamber

Speeches and statements in plenary debates, newest first; the verbatim report is on Parliament’s site.

26 contributions recorded; 2 on behalf of their group; 35 minutes of speaking time.

Date: the sitting. Debate: the item debated, and the group when they spoke on its behalf. Kind: speech or written statement, with speaking time. Verbatim: the verbatim report on Parliament’s site.
DateDebateKindVerbatim
16 Sept 2026Stop gold-plating, relieve SMEs: Member States must implement EU legislation without adding extra bureaucracy (topical debate) Speech · 1 minRead
8 Jul 2026EU’s response and preparedness to protect people against recurring heatwaves and upcoming wildfires (debate) Speech · 1 minRead
21 May 2026Need for an adaptation of the EU legal framework on sustainable biofuels (debate) Speech · 1 minRead
21 May 2026European Citizens’ Initiative ‘Stop destroying videogames’ (debate) Speech · 1 minRead
21 May 2026European Citizens’ Initiative ‘Stop destroying videogames’ (debate) Speech · 1 minRead
21 May 2026European Citizens’ Initiative ‘Stop destroying videogames’ (debate) Speech · 1 minRead
20 May 2026Reviewing the ETS system to support European competitiveness (topical debate) Speech · 2 minRead
28 Apr 2026Enforcement of the Digital Markets Act (debate) Speech · 1 minRead
28 Apr 2026Presentation of the Better Regulation and Enforcement Communication (debate) on behalf of S&DSpeech · 1 minRead
8 Oct 2025Europe’s automotive future – reversing the ban on the sale of combustion cars in the EU (topical debate) Speech · 2 minRead

Show all 26 recent contributions

Questions and motions, 20

Parliamentary questions and motions for resolutions the member authored or co-signed, newest first.

Date: tabled. Title: the question or motion, with its id. Kind: written question or motion for a resolution, with the number of co-authors. Answer: the date of the answer to a question.
DateTitleKindAnswer
14 Sept 2026Exclusion of purchases of Russian sable pelts from EU sanctions E-10-2026-003651Written questionwith 13 co-authorsNot yet answered
1 Jul 2026PROPOSAL FOR A DECISION requesting the Authority for European Political Parties and European Political Foundations to verify whether Europe of Sovereign Nations Party complies with the conditions laid down in Article 3(1), points (d) and (e), of Regulation (EU, Euratom) 2025/2445 B-10-2026-0338Motion for a resolutionwith 246 co-authors—
10 Jun 2026Potential conflict of interest in the appointment of the Special Envoy for Industrial AI P-10-2026-002401Priority written questionwith 37 co-authors13 Aug 2026
19 May 2026Biofuels and e-fuels in road transport E-10-2026-002077Written questionwith 5 co-authors14 Jul 2026
15 Apr 2026Cali fund – follow up from COP16 UN Convention on Biodiversity O-10-2026-000017Oral questionwith 2 co-authorsNot yet answered
23 Mar 2026MOTION FOR A RESOLUTION on the Commission delegated regulation of 3 February 2026 supplementing Regulation (EU) 2024/3012 of the European Parliament and of the Council by establishing the certification methodologies for permanent carbon removals activities B-10-2026-0181Motion for a resolutionwith 2 co-authors—
20 Feb 202612 months extension of the Supplementary Protection Certificate within the proposed European Biotech Act P-10-2026-000725Priority written question13 Apr 2026
3 Feb 2026Ensuring patient safety for all Europeans: the need to establish a warning system for disqualified medical professionals E-10-2026-000428Written questionwith 24 co-authors27 Mar 2026
5 Nov 2025Better regulation P-10-2025-004346Priority written question6 Jan 2026
5 Sept 2025A standardised LEZ sticker for cars E-10-2025-003461Written questionwith 3 co-authors8 Dec 2025

Show all 20 questions and motions

Amendments tabled in committee, 75

Committee amendment documents that carry amendments by the member, with how many are theirs.

Date: of the amendment document. Text amended: the dossier and the document’s id. Committee: where the amendments were tabled. Amendments: how many in the document are the member’s.
DateText amendedCommitteeAmendments
28 Jul 2026Amending Regulations (EU) 2017/745 and (EU) 2017/746 as regards simplifying and reducing the burden of the rules on medical devices and in vitro diagnostic medical devices, and amending Regulation (EU) 2022/123 as regards the support of the European Medicines Agency for the expert panels on medical devices and Regulation (EU) 2024/1689 as regards the list of Union harmonisation legislation referred to in its Annex I SANT-AM-791887 SANT51
28 Jul 2026Amending Regulations (EU) 2017/745 and (EU) 2017/746 as regards simplifying and reducing the burden of the rules on medical devices and in vitro diagnostic medical devices, and amending Regulation (EU) 2022/123 as regards the support of the European Medicines Agency for the expert panels on medical devices and Regulation (EU) 2024/1689 as regards the list of Union harmonisation legislation referred to in its Annex I SANT-AM-791891 SANT85
28 Jul 2026Amending Regulations (EU) 2017/745 and (EU) 2017/746 as regards simplifying and reducing the burden of the rules on medical devices and in vitro diagnostic medical devices, and amending Regulation (EU) 2022/123 as regards the support of the European Medicines Agency for the expert panels on medical devices and Regulation (EU) 2024/1689 as regards the list of Union harmonisation legislation referred to in its Annex I SANT-AM-791890 SANT66
15 Jul 2026General budget of the European Union for the financial year 2027 - all sections SANT-AM-789117 SANT18
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790937 CJ5320
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790934 CJ5332
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790939 CJ5313
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790933 CJ5335
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790953 CJ5324
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790005 CJ5310

Show all 75 amendment documents

Connections

Dossiers they lead or shadow, committees, party, delegation and other related pages.

Political group

National delegation

  • Delegation Germany National delegation

Sources & citation

Where the facts on this page come from, and how to cite it.

Data source
Licensed CC BY 4.0.
Data version
data version f37e5638cded (25 Sept 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1 · methods
Retrieved
25 September 2026

Cite as

EU Parl Watch Research (2026). “Tiemo WÖLKEN”. Member record. memberId 185619. EU Parl Watch Research. https://news.eu-parl.st-solutions.dev/members/185619?nb=all&page=6&scope=final (retrieved 25 September 2026). Official source: Member’s profile, European Parliament, https://www.europarl.europa.eu/meps/en/185619. Data: EP Open Data: member record, https://data.europarl.europa.eu/api/v2/meps/185619?format=application%2Fld%2Bjson (CC BY 4.0); data version f37e5638cded (25 Sept 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1.
BibTeX
@misc{epw-member-185619,
  author = {{EU Parl Watch Research}},
  title = {{Tiemo WÖLKEN}},
  year = {2026},
  howpublished = {\url{https://news.eu-parl.st-solutions.dev/members/185619?nb=all&page=6&scope=final}},
  url = {https://news.eu-parl.st-solutions.dev/members/185619?nb=all&page=6&scope=final},
  urldate = {2026-09-25},
  publisher = {EU Parl Watch Research},
  note = {Member record. memberId 185619. Official source: https://www.europarl.europa.eu/meps/en/185619. Data: EP Open Data: member record (CC BY 4.0); data version f37e5638cded (25 Sept 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1}
}